Context: Well-designed injection pen devices can help facilitate self-injection which may aid compliance. However, data are limited concerning product-specific features that drive patient and HCP preferences for these devices. Objective: To identify the key factors of injection devices that patients and nurses in Europe found most important to adoption of specific FSH treatments. Methods: Preferences of patients and nurses were obtained via an online questionnaire and evaluated using a conjoint analysis, which captures the relative importance of selected FSH injection device attributes to determine specific qualities in overall product preference. Patients and Nurses: We surveyed 402 patients in the EU5, Netherlands, and Belgium, and 40 IVF nurses in Germany, Italy, France, Spain and the Czech Republic. All patients were prescribed an FSH treatment in the past, either for an IVF or for an ovulation induction. Interventions: An online questionnaire was distributed and results were analyzed through multinomial logit modeling. Main Outcome Measures: Respondents’ preferences on the selected attributes were expressed as relative preference ranking normalized to sum to 100%. Results: For both patients and nurses, an ideal FSH injection device would be a highly accurate pen injector, which allows for multiple use, has a visibility feature, and enables patients to estimate residual cartridge contents. Conclusion: Patient preferences and nurse preferences are aligned on certain selected attributes of the IVF products. Our study was an unbranded examination of attributes across all injection devices currently on the market. However, our results showed that the preferred product attributes were all characteristic of the Ovaleap pen.